Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BCTXW
- Price
- 0.07
- Stock movement down
- -0.00 (-18.58%)
- Company name
- BriaCell Therapeutics Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- -
- Ent value
- 7.70M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -90.64%
- 3 year return
- -80.26%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BCTXW does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -0.29 |
| FCF per share (TTM) | -1.49 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -3.84K |
| Operating income (TTM) | -33.33M |
| Net income (TTM) | -4.79M |
| EPS (TTM) | -0.29 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 862.09K |
| Net receivables | 1.37M |
| Total current assets | 3.65M |
| Goodwill | 0.00 |
| Intangible assets | 199.80K |
| Property, plant and equipment | 456.80K |
| Total assets | 5.87M |
| Accounts payable | 7.17M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 7.46M |
| Total liabilities | 8.56M |
| Shareholder's equity | -2.68M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -24.13M |
| Capital expenditures (TTM) | 456.80K |
| Free cash flow (TTM) | -24.58M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -81.59% |
| Return on Invested Capital | 178.46% |
| Cash Return on Invested Capital | 915.59% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.02 |
| Daily Volume | 1K |
| All-time high | 6.55 |
| 1y analyst estimate | - |
| Beta | 1.41 |
| EPS (TTM) | -0.29 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BCTXW | S&P500 | |
| Current price drop from All-time high | -99.69% | -1.46% |
| Highest price drop | -99.69% | -56.47% |
| Date of highest drop | 21 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -61.04% | -10.99% |
| Avg time to new high | 28 days | 12 days |
| Max time to new high | 826 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner